109 related articles for article (PubMed ID: 9743841)
1. Risperidone in the management of agitation in HIV dementia.
Lodge P; Tanner M; McKeogh MM
Palliat Med; 1998 May; 12(3):206-7. PubMed ID: 9743841
[No Abstract] [Full Text] [Related]
2. The effect of risperidone on nursing burden associated with caring for patients with dementia.
Asghar Ali AA; Espinoza R; Kavirajan H; Read S
J Am Geriatr Soc; 2005 Jul; 53(7):1261-2; author reply 1262-3. PubMed ID: 16108953
[No Abstract] [Full Text] [Related]
3. Licensed indication for risperidone in dementia.
Phizackerley D
BMJ; 2014 Dec; 349():g7337. PubMed ID: 25498536
[No Abstract] [Full Text] [Related]
4. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
[TBL] [Abstract][Full Text] [Related]
5. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
[TBL] [Abstract][Full Text] [Related]
6. Duration of risperidone treatment for BPSD.
Snowdon J; Brodaty H; Ames D; Day S
Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
[No Abstract] [Full Text] [Related]
7. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
Corbett A; Burns A; Ballard C
BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
[No Abstract] [Full Text] [Related]
8. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Bogaisky M
Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109421
[No Abstract] [Full Text] [Related]
9. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
[TBL] [Abstract][Full Text] [Related]
10. An unsubstantiated conclusion.
Reifler BV; Blazer D
Am J Geriatr Psychiatry; 2015 Feb; 23(2):220. PubMed ID: 25575935
[No Abstract] [Full Text] [Related]
11. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
12. Risperidone for the treatment of delusional disorder due to HIV disease.
Maha A; Goetz K
J Neuropsychiatry Clin Neurosci; 1998; 10(1):111. PubMed ID: 9547476
[No Abstract] [Full Text] [Related]
13. Response to Bogaiksy's letter to the editor.
Freund-Levi Y; Jedenius E; Wahlund LO; Eriksdotter M; Tysen-Bäckström AC; Lärksäter M
Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109420
[No Abstract] [Full Text] [Related]
14. Risperidone for Psychosis-Induced Aggression or Agitation.
Scruth E
Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
[No Abstract] [Full Text] [Related]
15. Risperidone for AIDS-associated dementia: a case series.
Belzie LR
AIDS Patient Care STDS; 1996 Aug; 10(4):246-9. PubMed ID: 11361596
[TBL] [Abstract][Full Text] [Related]
16. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of risperidone in Alzheimer's disease.
Ling SM; Bonner AF; McMullen TL
N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
[No Abstract] [Full Text] [Related]
18. Discontinuation of risperidone in Alzheimer's disease.
Power GA
N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
[No Abstract] [Full Text] [Related]
19. Discontinuation of risperidone in Alzheimer's disease.
Gnjidic D; Hilmer SN
N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
[No Abstract] [Full Text] [Related]
20. Discontinuation of risperidone in Alzheimer's disease.
Devanand DP; Schultz SK; Sultzer DL
N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
[No Abstract] [Full Text] [Related]
[Next] [New Search]